Constructive Bio: New synbio firm launches in UK

In the United Kingdom, synthetic biology firm Constructive Bio has launched with $15 million in seed investment to scale and commercialize a platform to create new classes of enzymes, pharmaceuticals, and biomaterials. The technology is based on an exclusive license from the Medical Research Council of developed by Professor Jason Chin's Laboratory. The Chin Lab [...]